BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 21454842)

  • 1. More about osteonecrosis.
    Finkelman RD; Clemons M; Bouganim N
    J Am Dent Assoc; 2011 Apr; 142(4):371-2; author reply 372-4. PubMed ID: 21454842
    [No Abstract]   [Full Text] [Related]  

  • 2. Osteonecrosis of the jaw after zoledronic acid and denosumab treatment.
    Fusco V; Galassi C; Berruti A; Ciuffreda L; Ortega C; Ciccone G; Angeli A; Bertetto O
    J Clin Oncol; 2011 Jun; 29(17):e521-2; author reply e523-4. PubMed ID: 21537047
    [No Abstract]   [Full Text] [Related]  

  • 3. Osteonecrosis of the jaw.
    Drozdzowska B
    Endokrynol Pol; 2011; 62(1):88-92. PubMed ID: 21365586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Denosumab-related osteonecrosis of the jaws.
    Kyrgidis A; Toulis KA
    Osteoporos Int; 2011 Jan; 22(1):369-70. PubMed ID: 20306021
    [No Abstract]   [Full Text] [Related]  

  • 5. Osteonecrosis of the jaw and the role of macrophages.
    Pazianas M
    J Natl Cancer Inst; 2011 Feb; 103(3):232-40. PubMed ID: 21189409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteonecrosis of the jaw.
    Sari E; Bulut N; Altundag K
    J Am Dent Assoc; 2008 Apr; 139(4):398; author reply 398-400. PubMed ID: 18385020
    [No Abstract]   [Full Text] [Related]  

  • 7. [Avascular osteonecrosis of the jaws induced by diphosphonates].
    Lannoy D; Decaudin B; Barrier F; Bemba M; Wierre L; Pignon JM; Horrent S; Résibois JP; Wetterwald M; Odou P
    Therapie; 2006; 61(4):363-5. PubMed ID: 17124954
    [No Abstract]   [Full Text] [Related]  

  • 8. New oncology drugs and osteonecrosis of the jaw (ONJ).
    Migliorati CA; Covington JS
    J Tenn Dent Assoc; 2009; 89(4):36-8; quiz 38-9. PubMed ID: 20102031
    [No Abstract]   [Full Text] [Related]  

  • 9. Bisphosphonates and osteonecrosis of the jaw: a case report.
    Reiriz AB; De Zorzi Pde M; Lovat CP
    Clinics (Sao Paulo); 2008 Apr; 63(2):281-4. PubMed ID: 18438586
    [No Abstract]   [Full Text] [Related]  

  • 10. Bisphosphonate-induced osteonecrosis of the jaw requires early detection and intervention.
    Gibbs SD; O'Grady J; Seymour JF; Prince HM
    Med J Aust; 2005 Nov; 183(10):549-50. PubMed ID: 16296983
    [No Abstract]   [Full Text] [Related]  

  • 11. A new class of drugs to prevent osteoporosis may be associated with osteonecrosis of the jaw.
    Wynn RL
    Gen Dent; 2011; 59(1):10-2. PubMed ID: 21613033
    [No Abstract]   [Full Text] [Related]  

  • 12. Osteonecrosis of the jaws in newly diagnosed multiple myeloma patients treated with zoledronic acid and thalidomide-dexamethasone.
    Tosi P; Zamagni E; Cangini D; Tacchetti P; Di Raimondo F; Catalano L; D'Arco A; Ronconi S; Cellini C; Offidani M; Perrone G; Ceccolini M; Brioli A; Tura S; Baccarani M; Cavo M
    Blood; 2006 Dec; 108(12):3951-2. PubMed ID: 17114572
    [No Abstract]   [Full Text] [Related]  

  • 13. [Osteonecrosis associated with the use of biphosphonates: Case report].
    Anguita C T; Agurto P J; Roa E I; Laissle C G
    Rev Med Chil; 2006 Sep; 134(9):1161-5. PubMed ID: 17171218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiresorptive drug-related osteonecrosis of the jaw.
    Uyanne J; Calhoun CC; Le AD
    Dent Clin North Am; 2014 Apr; 58(2):369-84. PubMed ID: 24655528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Root canal therapy for the prevention of osteonecrosis of the jaws: an evidence-based clinical update.
    Kyrgidis A; Arora A; Lyroudia K; Antoniades K
    Aust Endod J; 2010 Dec; 36(3):130-3. PubMed ID: 21140589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteonecrosis of the jaws in patients with bone metastasis receiving intravenous bisphosphonates. A rising concern.
    Aguiar Bujanda D; Cabrera Suárez MA; Bohn Sarmiento U; Quintero Pérez S; Aguiar Morales J
    Clin Transl Oncol; 2006 Dec; 8(12):919-21. PubMed ID: 17169767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral osteonecrosis associated with the use of zoledronic acid: first case of a patient with advanced pancreatic cancer and bone metastases.
    Smith A; Kressley A; Saif MW
    JOP; 2009 Mar; 10(2):212-4. PubMed ID: 19287122
    [No Abstract]   [Full Text] [Related]  

  • 18. Denosumab for bone metastases from breast cancer: a new therapy option?
    Aapro MS
    J Clin Oncol; 2011 May; 29(14):e419-20; author reply e421-4. PubMed ID: 21464408
    [No Abstract]   [Full Text] [Related]  

  • 19. Osteonecrosis of the jaw.
    Friedlander AH
    J Am Dent Assoc; 2011 Apr; 142(4):370-1; author reply 372-4. PubMed ID: 21454841
    [No Abstract]   [Full Text] [Related]  

  • 20. [Osteonecrosis of the jaw in patients with multiple myeloma during and after treatment with zoledronic acid].
    Calvo-Villas JM; Tapia Torres M; Govantes Rodríguez J; Carreter de Granda E; Sicilia Guillén F
    Med Clin (Barc); 2006 Oct; 127(15):576-9. PubMed ID: 17153267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.